Edesa Biotech (EDSA) Assets (2013 - 2026)
Edesa Biotech (EDSA) posted Assets of $14.7 million for Q4 2025, up 8.72% sequentially from $13.5 million in Q3 2025, and up 253.26% YoY from $4.2 million in Q4 2024.
Edesa Biotech (EDSA) Assets (2013 - 2026) Analysis & Trends
Edesa Biotech has reported Assets for 13 years, with the latest figure at $14.7 million in Q4 2025.
- Quarterly Assets rose 253.26% year-over-year to $14.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.7 million (up 253.26% YoY) and the FY2025 annual result came in at $13.5 million, up 254.76% from the prior year.
- Assets advanced to $14.7 million in Q4 2025 per EDSA's latest filing, from $13.5 million in the prior quarter.
- Over five years, Assets peaked at $24.0 million in Q1 2021 and troughed at $3.8 million in Q3 2024.
- A 5-year average of $12.3 million and a median of $12.0 million in 2021 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets tumbled 57.1% in 2024, then soared 254.76% in 2025.
- Over 5 years, Assets stood at $12.3 million in 2021, then dropped by 5.42% to $11.7 million in 2022, then sank by 32.92% to $7.8 million in 2023, then tumbled by 46.83% to $4.2 million in 2024, then surged by 253.26% to $14.7 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $14.7 million, $13.5 million, and $14.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - | 12.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.72 Mn |
| Dec 31, 2025 | 14.71 Mn |
| Sep 30, 2025 | 13.53 Mn |
| Jun 30, 2025 | 14.80 Mn |
| Mar 31, 2025 | 16.45 Mn |
| Dec 31, 2024 | 4.16 Mn |
| Sep 30, 2024 | 3.81 Mn |
| Jun 30, 2024 | 5.23 Mn |
| Mar 31, 2024 | 6.48 Mn |
| Dec 31, 2023 | 7.83 Mn |
| Sep 30, 2023 | 8.89 Mn |
| Jun 30, 2023 | 9.42 Mn |
| Mar 31, 2023 | 10.67 Mn |
| Dec 31, 2022 | 11.67 Mn |
| Sep 30, 2022 | 11.58 Mn |
| Jun 30, 2022 | 17.54 Mn |
| Mar 31, 2022 | 20.41 Mn |
| Dec 31, 2021 | 12.34 Mn |
| Sep 30, 2021 | 14.58 Mn |
| Jun 30, 2021 | 16.88 Mn |